1. Companies

  2. Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals.
Launch date
Employees
10001+ people
Ingelheim am Rhein Rhineland-Palatinate (HQ)
http://boehringer-ingelheim.com
https://twitter.com/boehringerhttps://www.facebook.com/boehringeringelheimhttps://www.linkedin.com/company/boehringer-ingelheim
View job openings
Corporate Venture Fund: Boehringer Ingelheim Venture Fund
    • Edit
DateInvestorsAmountRound

N/A

Spinout
Total Funding-

Related Content

Recent News about Boehringer Ingelheim

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
By Country
United States 6Switzerland 4Canada 2Belgium 2India 1Austria 1China 1Kenya 1Ghana 1Germany 1
By Industry
Health 20Food 1
By Round
ACQUISITION 10EARLY VC 3POST IPO EQUITY 2GROWTH EQUITY VC 1SERIES A 1NOT SET 1DEBT 1SERIES C 1SUPPORT PROGRAM 1
    • Edit
MabVax Therapeutics
MabVax Therapeutics
exited
Actimis Pharmaceuticals
Actimis Pharmaceuticals
ACQUISITION by Boehringer Ingelheim Jun 2008
Lupin
Lupin
Amal Therapeutics
Amal Therapeutics
ACQUISITION by Boehringer Ingelheim Jul 2019
NBE-Therapeutics
NBE-Therapeutics
ACQUISITION by Boehringer Ingelheim Dec 2020
T3 Pharmaceuticals
T3 Pharmaceuticals
ACQUISITION by Boehringer Ingelheim Nov 2023
Vira Therapeutics
Vira Therapeutics
ACQUISITION by Boehringer Ingelheim Sep 2018
Ruipeng Pet Medical Group
Ruipeng Pet Medical Group
Phenomic AI
Phenomic AI
Ilara Health
Ilara Health
View 49 more